Federal prosecutors blast back at a move by Stryker Corp.'s biotech subsidiary and several executives to have criminal charges dismissed in a federal case alleging the illegal promotion of bone putties.
Federal prosecutors blasted Stryker Corp.'s (NYSE:SYK) biotech subsidiary, its former president and three sales reps for seeking the dismissal of the bulk of the 16 criminal charges pending against them in a federal case alleging the illegal promotion of bone putties.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.